Literature DB >> 10973811

Protein delivery by Pseudomonas type III secretion system: Ex vivo complementation of p67(phox)-deficient chronic granulomatous disease.

B Polack1, S Vergnaud, M H Paclet, D Lamotte, B Toussaint, F Morel.   

Abstract

Bacterial type III secretion system drives the translocation of virulence factors into the cystosol of host target cells. In phagocytes and in Epstein-Barr virus immortalized B lymphocytes, NADPH oxidase generates O(-2) through an electron transfer chain the activity of which depends on the assembly of three, p67(phox), p47(phox) and p40(phox) cytosolic activating factors with Rac 1/2 and a membrane redox component, cytochrome b(558). In p67(phox) deficient chronic granulomatous disease (CGD) patients, p67-phox is missing and NADPH oxidase activity is abolished. ExoS is a virulence factor of Pseudomonas aeruginosa which is secreted via the type III secretion system: it was fused with p67(phox). Pseudomonas aeruginosa synthesized and translocated the hybrid ExoS-p67(phox) fusion protein into the cytosol of B lymphocytes via the type III secretion system. Purified ExoS-p67(phox) hybrid protein was as efficient as normal recombinant p67(phox) in cell-free reconstitution of NADPH oxidase activity. Therefore, ExoS-p67(phox) was transferred via the type III secretion system of Pseudomonas aeruginosa into the cytosol of B lymphocytes from a p67(phox)-deficient CGD patient and functionally reconstituted NADPH oxidase activity. In the complementation process, ExoS acted as a molecular courier for protein delivery: the reconstitution of an active NADPH oxidase complex suggests type III secretion system to be a new approach for cellular therapy. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973811     DOI: 10.1006/bbrc.2000.3399

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Bacterial vectors for active immunotherapy reach clinical and industrial stages.

Authors:  Audrey Le Gouëllec; Xavier Chauchet; Benoit Polack; Laurent Buffat; Bertrand Toussaint
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

Review 2.  Bacterial type III secretion system as a protein delivery tool for a broad range of biomedical applications.

Authors:  Fang Bai; Zhenpeng Li; Akihiro Umezawa; Naohiro Terada; Shouguang Jin
Journal:  Biotechnol Adv       Date:  2018-02-02       Impact factor: 14.227

3.  High-yield production of secreted active proteins by the Pseudomonas aeruginosa type III secretion system.

Authors:  M Derouazi; B Toussaint; L Quénée; O Epaulard; M Guillaume; R Marlu; B Polack
Journal:  Appl Environ Microbiol       Date:  2008-04-04       Impact factor: 4.792

4.  Optimal epitope composition after antigen screening using a live bacterial delivery vector: application to TRP-2.

Authors:  Madiha Derouazi; Yan Wang; Raphaël Marlu; Olivier Epaulard; Jean-François Mayol; Nicolas Pasqual; Audrey Le Gouellec; Benoit Polack; Bertrand Toussaint
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

5.  Bacterium-Derived Cell-Penetrating Peptides Deliver Gentamicin To Kill Intracellular Pathogens.

Authors:  Marta Gomarasca; Thaynan F C Martins; Lilo Greune; Philip R Hardwidge; M Alexander Schmidt; Christian Rüter
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Bacterial delivery of nuclear proteins into pluripotent and differentiated cells.

Authors:  Candace Bichsel; Dennis K Neeld; Takashi Hamazaki; Donghai Wu; Lung-Ji Chang; Lijun Yang; Naohiro Terada; Shouguang Jin
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

7.  Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation.

Authors:  Sylvie Berthier; Minh Vu Chuong Nguyen; Athan Baillet; Marc-André Hograindleur; Marie-Hélène Paclet; Benoît Polack; Françoise Morel
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

8.  Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.

Authors:  Xavier Chauchet; Dalil Hannani; Sophia Djebali; David Laurin; Benoit Polack; Jacqueline Marvel; Laurent Buffat; Bertrand Toussaint; Audrey Le Gouëllec
Journal:  Mol Ther Oncolytics       Date:  2016-12-14       Impact factor: 7.200

Review 9.  Intracellular delivery of biologic therapeutics by bacterial secretion systems.

Authors:  Barnabas James Walker; Guy-Bart V Stan; Karen Marie Polizzi
Journal:  Expert Rev Mol Med       Date:  2017-04-06       Impact factor: 5.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.